npj Precision Oncology Онкология

Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment

Elizabeth J. Shaughnessy, Abde M. Abukhdeir, Thomas R. Battersby, Bowen Cui, Simon P. Dearden, Lindee Goh, Janet Y. Jin, Alexander G. Kohlmann, Kelly S. Oliner, Scott D. Patterson, Danielle M. Townsley, Sophie E. Wildsmith, Barbara A. Zehnbauer
Springer Nature · 2026-11-18 · DOI 10.1038/s41698-026-01765-8

Аннотация

npj Precision Oncology, Published online: 18 November 2026; doi:10.1038/s41698-026-01765-8 Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment

Читать у издателя →